Allied Diseases

Allied Diseases is a specialized biotechnology and research company focused on the development of therapeutic solutions for liver-related conditions and infectious diseases. The company primarily targets viral hepatitis (HBV and HCV) and chronic liver diseases such as cirrhosis and non-alcoholic steatohepatitis (NASH). Allied Diseases operates by conducting clinical research and collaborating with larger pharmaceutical entities to advance its pipeline of small molecules and biologics. Their business model emphasizes the translation of academic research into viable clinical candidates for underserved patient populations in the hepatology space. The company is recognized for its contributions to liver disease diagnostics and treatment protocols.